Archive for - Company Profiles

Toxem — Company Profile

Toxem SARL
73 rue Martainville
76000 Rouen
France

Tel.: +33 (0)6 19 35 73 11
Fax: +33 (0)2 32 10 23 02
Email: contact@toxem.com
Website: http://www.toxem.com/

Established in 2008, TOXEM is an innovative biotechnology company specializing in high-throughput screening of mutagenicity.

Using conventional tests developed for HTS use , TOXEM helping with low cost to accelerate the pace of new molecules development in the pharmaceutical and cosmetical industries. TOXEM is also specializes in the development of new tests using the human TP53 tumor supressor gene.

Laboratories:
Faculté de médecine — Batiment de recherche
22, boulevard Gambetta
76183 Rouen cedex 1
France

Source: Toxem

Leave a Comment

B Cell Design — Company Profile

B Cell Design
Faculté de Médecine de Limoges
2, rue du Docteur Marcland
87025 Limoges Cedex
France

Tel.: +33 (0)5 55 43 59 37
Fax: +33 (0)5 55 43 59 37
Website: http://www.b-cell-design.com/

B Cell Design Development and production of humanised antibodies — a service provider activity, producing humanised IgA or IgG &mdash R&D activity for the development of humanised antibodies.

B Cell Design has been created in December 2007 and is a biotech lodged in Limoges university.

Source: B Cell Design

Leave a Comment

Holodiag — Company Profile

Holodiag
Place Emile Blondel
76821 Mont Saint Aignan Cedex
France

Tel.: +33 (0)2 35 14 67 82
Fax: +33 (0)2 35 14 67 83
Email: contact@holodiag.com
Website: http://www.holodiag.com/

Holodiag is a R&D company providing services for the development and the optimization of crystallization processes for fine chemical industries. The prevailing issues managed by Holodiag are post-screening polymorphism and enantiomer separation by crystallization. Holodiag’s laboratory is available for analytical services : X-ray powder diffraction, DSC and TGA.

The Holodiag’s research team, originally trained in the laboratory of Professor Gérard Coquerel, masters the following fields:

  • Crystallization (small organic molecules)
  • Thermodynamics of heterogeneous equilibria
  • Phase diagrams
  • Crystallography
  • Molecular modeling

Source: Holodiag

Leave a Comment

PCAS — Company Profile

PCAS
BP 181
23, rue Bossuet
Z.I. La Vigne aux Loups
91160 Longjumeau
France

Tel.: +33 (0)1 69 09 77 85
Fax: +33 (0)1 69 74 81 04
Email:infopharma@pcas.fr
Website: http://www.pcas.fr/

PCAS is the special partner of pharmaceutical laboratories for the development, production and market launch of bulk APIs.

PLANTS:

Usine de Bourgoin
15, avenue des frères-Lumière
38300 Bourgoin-Jallieu
France
Tel.: +33 (0)4 74 93 63 33
Fax: +33 (0)4 74 28 29 98

Usine de Couterne
Route de Lassay
61410 Couterne
France
Tel.: +33 (0)2 33 37 50 20
Fax: +33 (0)2 33 37 50 21

Usine de Limay
19, route de Meulan
78520 Limay
France
Tel.: +33 (0)1 34 78 87 87
Fax: +33 (0)1 30 92 03 46

EXPANSIA

Headquarters
BP 181
23, rue Bossuet
ZI de la Vigne-aux-Loups
91160 Longjumeau
France
Tel.: +33 (0)1 69 09 77 85
Fax: +33 (0)1 64 48 23 19

Plant
Route d’Avignon
30390 Aramon
France
Tel.: +33 (0)4 66 57 01 01
Fax: +33 (0)4 66 57 01 48

SOCIÉTÉ BÉARNAISE DE SYNTHÈSE

Headquarters
BP 181
23, rue Bossuet
ZI de la Vigne-aux-Loups
91160 Longjumeau
France
Tel.: +33 (0)1 69 09 77 85
Fax: +33 (0)1 64 48 23 19

Plant
Plateforme Sobegi
Pôle 4
Avenue du Lac /R.D.281
64150 Mourenx
France
Tel.: +33 (0)5 59 92 75 33
Fax: +33 (0)5 59 92 75 31

VLG CHEM

Headquarters
BP 181
23, rue Bossuet
ZI de la Vigne-aux-Loups
91160 Longjumeau
France
Tel.: +33 (0)1 69 09 77 85
Fax: +33 (0)1 64 48 23 19

Plant
35, avenue Jean-Jaurès
92390 Villeneuve-La-Garenne
France
Tel.: +33 (0)1 46 85 91 91
Fax: +33 (0)1 46 85 91 61

PROTEUS

Headquarters
70, allée Graham Bell
Parc Georges Besse
30000 Nîmes
Tel.: +33 (0)4 66 70 64 64
Fax: +33 (0)4 66 70 64 60
www.proteus.fr

Source: PCAS

Leave a Comment

PCAS Biosolution — Company Profile

PCAS Biosolution SAS
70, allée Graham Bell
Parc Georges Besse
30000 Nîmes
France

Tel.: +33 (0)4 66 27 29 21
Fax: +33 (0)4 66 27 29 20
Email:info@pcas-bio.com
Website: http://www.pcas-bio.com/

PCAS Biosolution is a joint-venture created in 2006 by PCAS and Protéus with headquarters in Longjumeau, France and operating facilities located in the South of France. PCAS Biosolution aims at providing our customers all the value drivers of integrating biocatalysis into chemical processes.

Headquarters
23, rue Bossuet
Z.I. de la Vigne Aux Loups
91160 Longjumeau
France

Vision & Strategy

PCAS Biosolution integrates chemistry and biotechnology to provide a unique and exclusive offering to the pharmaceutical industry.

The Company combines and integrates multidisciplinary expertise, proprietary technologies and multi-scale production capabilities in both chemistry and biotechnology. We focus on the synthesis of APIs, intermediates and building blocks using chemo-biocatalytic manufacturing routes. Biocatalytic steps provide scalability, versatility and a high chemo-, regio-, stereo- and enantioselectivity.

Benefits include the ability to produce complex intermediates and APIs using scalable routes, reduce manufacturing costs, improve productivity, reduce byproducts and develop competitive green chemistry process.

We are committed to be your quality partner for the development, manufacture and long term supply of your intermediates and APIs using the optimal chemo-biocatalytic routes that meet your specifications of quantity, time, quality and targeted price.

Mission

Our mission is to provide significant value to drug developers by designing, developing and implementing new cost-effective and scaleable manufacturing routes to APIs and intermediates which combine both chemistry and biotechnology.
The company aims at creating brand new routes to innovative products or at improving the manufacturing process of currently marketed products. Our focus is on reducing the number of manufacturing steps, decreasing by-products, avoiding hazardous chemicals, using lower cost raw material, enhancing purity and process enantio-selectivity, increasing conversion rate and improving overall yield, energy consumption and performance.

More value also means more Industrial Property: biocatalysts and processes developed are generally proprietary, thus providing opportunities to the drug developers to reinforce and extend the lifetime of their existing intellectual property.

With PCAS Biosolution, your projects will benefit from a unique, comprehensive and integrated chemo-biocatalytic R&D, industrial and regulatory platform.

Source: PCAS Biosolution

Leave a Comment

IDD-Tech — Company Profile

IDD-Tech
International Drug Development Technopole
27, chemin des Peupliers
BP 66
69572 Dardilly Cedex
France

Tel.: +33 (0)4 72 17 27 11
Fax: +33 (0)4 78 35 76 48
E-mail:
lyonoffice@idd-tech.com
Website: http://www.idd-sa.com/tech/en/

IDD-Tech is a research and development technical centre for healthcare products and the cosmetics industry.

At the heart of the healthcare industry

The IDD-Tech site in Dardilly, 10km outside Lyon, is strategically located within easy reach of the region’s international airports and dense rail and road networks, and is surrounded by other outstanding scientific centres working in the healthcare industry. This exceptional business setting led to the area being granted the government’s prestigious "competitive cluster" status in July 2005.

International expertise

Until 2005, the Dardilly plant was one of Schering Plough’s leading research and development sites. Supported by its highly professional workforce and state-of-the-art equipment, IDD-Tech is a player on an international scale working to the highest regulatory standards (FDA – EMEA – Japan).

A global approach to development

IDD-Tech can offer its clients step-by-step management of the whole development process, from preformulation through to the manufacture and release of pilot batches of all pharmaceutical forms (solid, liquid, sterile) and biotechnology products (lyophilisates), all on one site.

IDD-Tech is a pharmaceutical plant and is qualified to manufacture and release clinical trial batches.

The IDD-Tech site in Dardilly

Analytical Development

Formulation Development

Quality Control

Cold Generator System

Purified Water System

Steam Generator

Source: IDD-Tech

Leave a Comment

Novasep — Company Profile

Groupe Novasep
82, boulevard de la Moselle
BP 50
54340 Pompey
France

Tel.: +33 (0)3 83 49 71 30
Fax: +33 (0)3 83 49 71 40
Email: novasep@novasep.com
Website: http://www.novasep.com/

Innovative and cost effective purification solutions and chemistry for the life-science industries.


St Maurice de Beynost
Purification processes for industrial biotech products

5, chemin du Pilon
St Maurice de Beynost
01708 Miribel
France

Tel.: +33 (0)4 72 01 27 27
Fax: +33 (0)4 72 25 88 99
Email: industrialbiotech@novasep.com
Website: http://www.novasep.com/Novasep-Process/Site/site-applexion.asp

Pompey
Purification processes for pharmaceuticals

Boulevard de la Moselle
BP 50
54340 Pompey
France

Tel.: +33 (0)3 83 49 70 00
Fax: +33 (0)3 83 49 70 02
Email: pharma@novasep.com
Website: http://www.novasep.com/Novasep-Process/Site/site-novasep.asp

Brabois
Purification processes for biopharmaceuticals

13, rue du bois de la Champelle
54500 Vandoeuvre-lès-Nancy
France

Tel.: +33 (0)3 83 49 70 00
Fax: +33 (0)3 83 49 70 02
Email: novasep@novasep.com
Website: http://www.novasep.com/Novasep-Process/Site/site-bioprocess.asp

Le Mans
HPAIs synthesis and purification

Rue Démocrite
72000 Le Mans
France

Tel.: +33 (0)2 43 39 94 40
Fax: +33 (0)2 43 39 94 49
Email: seripharm@novasep.com
Website: http://www.novasep.com/Novasep-Synthesis/Site/site-seripharm-lemans.asp

Chasse/Rhône
Exclusive synthesis services from early stage to commercial supply

Route de Givors
38670 Chasse-sur-Rhône
France

Tel.: +33 (0)4 72 49 19 60
Fax: +33 (0)4 72 49 19 73
Email: finorga@novasep.com
Website: http://www.novasep.com/Novasep-Synthesis/Site/site-finorga-chasse.asp

Mourenx
Exclusive synthesis services from early stage to commercial supply

Avenue du Lac
64150 Mourenx
France

Tel.: +33 (0)5 59 60 79 00
Fax: +33 (0)5 59 60 79 49
Email: finorga@novasep.com
Website: http://www.novasep.com/Novasep-Synthesis/Site/site-finorga-mourenx.asp

Source: Novasep

Leave a Comment

Polyintell — Company Profile

Polyintell SAS
15, rue de la Carue
76000 Rouen
France

Tel.: +33 (0)2 35 52 24 30
Fax: +33 (0)2 35 52 24 30
Email: contact@polyintell.com
Website: http://www.polyintell.com/

POLYINTELL is a private company having special competency on the development of innovative polymers for applications in life and pharmaceutical sciences.

Our expertise covers:

  • Molecularly Imprinted Polymers from nano systems to monoliths
  • Intelligent coating and hydrogel

Our aim is to create and develop innovative polymers that meet unsatisfied needs of life sciences and to help our clients in their problem solving.

POLYINTELL’s core strategy is to build on its internal expertise in the areas of intelligent polymer in order to provide customer with innovative polymers for their needs. Our investment in Research & Development is the key to our future growth.

History

POLYINTELL was founded in July 2004 based of skill of successful Scientifics in Upper-Normandy (France).

Thanks to its innovations, POLYINTELL is the winner of the Contest of Innovative and Technological Companies of the French Ministry of Research &Technology and the ESF, in 2004.

POLYINTELL was awarded for the third Special Prize of the national jury of the Contest of Innovative and Technological Companies of the French Ministry of Research&Technology in 2004.

We are supported by ANVAR, the incubator Acceval and the Regional Council.

Laboratories:
Sis IRCOF
Rue Lucien Tesnière
76130 Mont Saint Aignan
France

Source: Polyintell

Leave a Comment

MidiMed — Company Profile

MidiMed
ZI du Bousquet
31360 Boussens
France

Tel.: +33 (0)5 61 97 69 69
Fax: +33 (0)5 61 87 17 59
Website: http://www.midimed.com/

MidiMed manufactures reagents for cell culture. We are committed to provide quality products and services to research laboratories and industrialists according to their needs.

  • Standard and innovative culture media,
  • Additives and antibiotics,
  • Sera, albumins, plasma of most species and origins,
  • Immunoglobulins,
  • An innovative serum free range of products, "SafeCell".

MidiMed was created in July 2004; our 2000 m2 factory located in Boussens, south of Toulouse offers you:

  • Standard and customized Culture media.
  • Serum Free media, based on containing vegetable extracts.
  • Serums and plasma of most species and origins.
  • Capacity to produce lots above 1000 litres.
  • Additives and antibiotics for cell culture.
  • Albumins and immunoglobulins.

The MidiMed company invested in several research projects in order to replace animal proteins by plant proteins.

Source: MidiMed

Leave a Comment

LemnaGene — Company Profile

LemnaGene
Espace Florentin
71, chemin du Moulin Carron
69570 Dardilly
France

Website: http://www.lemnagene.com/

LemnaGene SA, offers a new era in Biomanufacturing.

Created in October 2003, LemnaGeneTM is since July 2005 a fully owned subsidiary of Biolex Therapeutics.

LemnaGeneTM has obtained an ANVAR Grant from the French Research Ministry in 2003.

LemnaGeneTM is based in Lyon, France, the 8th largest economic region in Europe with a high density in Life Science activities.

LemnaGeneTM has signed a Research & Development Agreement with Bayer CropScience, BioScience, to investigate the expression of aprotinin in lemna.

In addition, LemnaGeneTM has secured several agreements with other Industrial Partners in the pharma and human/animal vaccine areas.

Lemna

Lemna is a unique PMP (Plant Made Protein) Platform meeting industrial requirements as well as safety concern. Lemna is a recent option that offers its own advantages compared to other plant species. Belonging to Lemnaceae, Duckweed is a group of small, free-floating, fresh water plants, used as feed and food, mostly in Asian countries. It is also used in North America for waste-water management.

Main Advantages of Lemna for the production of recombinant proteins:

Due to its easy clonal propagation on water containing salts using light and CO2, Lemna is a choice organism for the production of recombinant proteins. The Weizmann Institute, team of Meir Edelman and Avi Perl have designed unique conditions for the insertion of genes and the growth of Lemna to obtain high protein production.
Lemnaceae thus offer numerous advantages compared to other technologies used for biomanufacturing such as:

  • Security and safety, for both the environment (all steps including the production, are done under confined conditions) and for human and animal since there is no risk of viral contamination;
  • High productivity due to its rapid growth (doubling time is about two days) and a high protein content (45% of dry weight);
  • Flexibility since production can be done during all year around and also production capacity can easily be adapted to the needs;
  • Speed from access to the gene to the commercialisation;
  • Low costs due to low capital investment and running costs.

Products

LemnaGeneTM is using its technology to produce several types of active ingredients dedicated to different market areas:

  • Recombinant proteins for the pharmaceutical and veterinary industry;
  • Recombinant vaccines for humans and animals;
  • Feed additives such as enzymes or probiotics;
  • Enzymes and monoclonal antibodies for diagnostics and laboratory reagents.

The active ingredient produced can be delivered in different formats:

Pure: The active ingredient can be purified and used as drugs or vaccines;

Dry: Lemna can be dried and sold as a powder in the form of capsules or tablets; It can also be sprayed on feed for animals during the formulation process of the feed;

Fresh: Non-transgenic Lemna has been already sold as salads for human consumption and is widely used as animal feed in developing countries.

Source: LemnaGene

Editor’s note: LemnaGene does not exist anymore.

Leave a Comment

Older Posts »
Follow

Get every new post delivered to your Inbox.